Cannabinoid CB2 receptors in human brain inflammation

Area of Science:

• Neuroscience
• Pharmacology
• Immunology

Background:

• The cannabinoid receptor 2 (CB2) was historically considered a peripheral receptor, but recent evidence confirms its presence in the central nervous system (CNS).
• Unlike the cannabinoid receptor 1 (CB1), CB2 receptors are inducible under neuroinflammatory conditions, presenting a unique therapeutic target.
• CB1 receptor activation is associated with undesired psychoactive effects, limiting the clinical application of related compounds.

Purpose of the Study:

• To review recent findings on the anti-inflammatory properties of CB2 receptors in the CNS.
• To present new perspectives based on human postmortem brain sample studies.
• To discuss novel working hypotheses regarding CB2 receptor function in neurological conditions.

Main Methods:

• Review of recent scientific literature on CB2 receptors in the CNS.
• Analysis of data from human postmortem brain samples.
• Discussion of proposed working hypotheses and existing research.

Main Results:

• Confirmation of CB2 receptor presence in specific brain regions of humans and other species.
• Evidence supporting the anti-inflammatory role of CB2 receptors in neuroinflammatory contexts.
• Identification of CB2 receptors as a potential target for novel therapeutics with reduced psychoactive effects.

Conclusions:

• CB2 receptors are functionally present in the CNS and play a role in neuroinflammation.
• Targeting CB2 receptors offers a promising therapeutic strategy for CNS disorders, distinct from CB1-mediated pathways.
• Further research into CB2 receptor mechanisms could unlock new treatments for neurological diseases.